Nailba 2025 is a strategic plan developed by the National Institute of Allergy and Infectious Diseases (NIAID) to accelerate the development of new vaccines and treatments for HIV/AIDS. The plan was launched in 2015 and has a goal of ending the HIV/AIDS pandemic by 2025.
Nailba 2025 is based on the latest scientific advances in HIV/AIDS research and is designed to address the challenges of developing new vaccines and treatments. The plan includes a focus on developing new vaccines that are more effective and durable, as well as new treatments that are more effective and less toxic. Nailba 2025 also includes a focus on developing new strategies to prevent HIV/AIDS transmission and to improve the quality of life for people living with HIV/AIDS.
